Holen Sie sich die Stockscreener-App
1.62
4.71%
-0.08
Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
5.81%
3.696
|
3.924 | 3.535 | 4.044 | 3.328 |
| Operating Income/Loss |
5.76%
-6.443
|
-6.837 | -5.996 | -7.61 | -6.226 |
| Income/Loss From Continuing Operations After Tax |
5.09%
-6.356
|
-6.697 | - | -7.549 | -6.204 |
Net Income/Loss
|
5.09%
-6.356
|
-6.697 | -5.806 | -7.549 | -6.204 |
| Basic Average Shares |
12.79%
1.1964
|
1.0607 | - | 4.049 | 0.7381 |
| Diluted Average Shares |
12.79%
1.1964
|
1.0607 | - | 4.049 | 0.7381 |
| Basic Earnings Per Share |
17.16%
-5.31
|
-6.41 | - | -2.23 | -8.40 |
| Diluted Earnings Per Share |
17.16%
-5.31
|
-6.41 | - | -2.23 | -8.40 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):